It is also likely that EGFR is one of the target molecules for the rTBL-1, and many other membrane glycoproteins could be interacting, as aberrant sialylation and fucosylation are common in other glycoproteins involved in the development of many types of cancers, including colon cancer. The gene discussed is EGFR; the disease is cancer.